TLDR
- Altria (MO) hit a new 52-week high of $76.17, last trading at $76.48
- Q1 EPS of $1.32 beat estimates of $1.25; revenue of $4.76B beat expectations by $180M
- Full-year 2026 EPS guidance set at $5.56–$5.72
- Quarterly dividend of $1.06 per share represents a 5.5% yield
- Consensus analyst rating is “Hold” with an average price target of $70.78
MO hit a new 52-week high on Tuesday, touching $76.17 before settling around $76.48 — well above its previous close of $72.89. The stock is up 30.45% year-to-date and has returned 32.55% over the past year.
The move comes after a strong earnings beat last quarter. Altria posted EPS of $1.32 against a consensus estimate of $1.25. Revenue came in at $4.76 billion, up 5.3% year over year, and beat analyst expectations of $4.58 billion.
For full-year 2026, the company guided for EPS of $5.56 to $5.72. Analysts are currently projecting $5.70 for the year.
Dividend Still a Draw
Altria paid a $1.06 quarterly dividend on July 10, representing an annualized payout of $4.24 and a yield of around 5.5%. The company has now maintained its dividend for 56 consecutive years.
The payout ratio sits at 88.7%, which is high, but the income profile continues to attract yield-focused investors.
Two directors did sell stock in May. Debra J. Kelly sold 5,790 shares at $72.25, reducing her position by 7.27%. Ellen R. Strahlman sold 2,000 shares at $72.56, a 7.38% reduction. Both transactions were disclosed with the SEC.
Institutional investors hold 57.41% of the stock. Several funds added to positions in recent quarters, including Bernardo Wealth Planning, which increased its stake by 4.6% in Q2.
Analyst Ratings Mixed
The consensus rating on MO is “Hold,” with an average price target of $70.78 — below where the stock is currently trading.
UBS has a Buy rating with a $79 price target. Bank of America adjusted its estimates after favorable regulatory changes in the tobacco sector in Q2. BTIG initiated coverage in July with a Neutral rating.
Citigroup raised its target from $65 to $70 with a Neutral rating. Morgan Stanley holds a $71 target. Jefferies has an Underperform rating with a $60 target. Among the 12 analysts covering the stock, five rate it a Buy, five Hold, and two Sell.
The FDA recently proposed a rule requiring foreign tobacco manufacturers to register their facilities. That proposal was seen as a positive for domestic producers like Altria.
Oral tobacco sales showed growth through late May, while cigarette and vapor sales declined, according to Bank of America data.
MO has a market cap of $127.82 billion, a P/E ratio of 16.01, and a beta of 0.45. Its 50-day moving average is $71.90 and the 200-day is $67.95.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
